Krishna Institute of Medical Sciences: History

• The very first hospital from the KIMS Group was founded in the year 2000 at Nellore (Andhra Pradesh) by Dr. Bhaskar Rao Bollineni (a cardiac surgeon) who has performed 30,000 plus surgeries.
• In the year 2004, KIMS group’s flagship hospital, krishna institute of medical sciences, secunderabad hospital was established, which is now a 1000-bedded hospital.
• In the year 2015, KIMS Hospital received the first “Green Operation Theater” certification in Telangana and Andhra Pradesh.
• The company successfully raised INR 2170 Cr through krishna institute of medical sciences limited ipo in the year 2021 and became a publicly listed company.

Krishna Institute of Medical Sciences: Business

(KIMS) Hospitals is one of the largest corporate healthcare groups in India with hospitals in Andhra Pradesh, Telangana, and Maharashtra.

The Company offers a bouquet of comprehensive healthcare services across 25 specialties including Cardiology, Cardiothoracic and Cardiovascular surgery, Dermatology, Dental, Diabetology, ENT, Gastroenterology, Oncology, Nephrology, Neurology, Neurosurgery, Obstetrics & Gynecology, Organ Transplantation, Orthopedics, Pediatrics, Pulmonology, Plastic Surgery, Rheumatology, Robotics and Urology.

The KIMS Hospital Group is certified by NABH (National Accreditation Board for Hospitals) and NABL (National Accreditation Board for Testing and Calibration Laboratories).

Total Bed Capacity

The company operates 13 multi-specialty hospitals across the states of Andhra Pradesh, Telangana, and Maharashtra under the KIMS Hospitals brand, with an aggregate bed capacity of 4000.

The KIMS Group has hospitals in Secunderabad, Hyderabad, Visakhapatnam, Nagpur, Kondapur, Ongole, Rajahmundry, Srikakulam, Nellore, Anantapur, and Kurnool.

Affordable Pricing Model

The Company has successfully implemented its affordable pricing model in its hospitals.

In Tier 1 cities, their prices across medical procedures are on average 20 to 30 percent lower than other private hospitals in the country.

In FY22, their Analysis of ROI for Pharmaceutical Promotion (ARPP) is INR 121,232, which has improved from INR 84,388 in FY18.

Listed On:

The share of Krishna Institute of Medical Sciences Ltd is presently listed on the Bombay Stock Exchange (BSE); CODE 543308 and National Stock Exchange (NSE) as KIMS

Stock Info: Krishna Institute of Medical Sciences

Share Holding Pattern

Financials

Conclusion

KIMS is one of the largest corporate healthcare groups in India; providing multi-disciplinary integrated healthcare services at an affordable cost.

Promoters of the company are having more than 38 percent stake.

Along with this, some of the top institutions like Nomura India Investment Fund Mother Fund, Mirae Asset Emerging Bluechip Fund, Axis Mutual Fund Trustee Limited, India Advantage Fund, Hdfc Life Insurance Company Limited, Tata AIA Life Insurance Co Ltd, and General Atlantic Singapore Kh Pte Ltd is having more than a 1% stake in the company (as of June 2022).

Krishna Institute of Medical Sciences consolidated numbers for June 2022; Net Sales at INR 495.5 Cr (UP 4.8% Y-O-Y and 33% Q-O-Q) while Net Profit at INR 79.25 Cr

On the technical front, KIMS share is trading above its 20 EMA (1361) and 50 EMA (1297) on the daily chart.

Keeping the above-listed factors in mind, KIMS looks good at INR 1450. Finblab recommends investing in the stock in a staggered manner for the medium to the long haul (3 to 5 years period).

Also Read: Can Fin Homes Limited – Value Pick Stock September 2022

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

The post Krishna Institute of Medical Sciences Ltd: Value Pick Stock October 2022 appeared first on Upcoming ipos: Latest news on stocks, economy & finance.

Shalby Hospital – Company Profile

• Shalby Hospitals (Shalby Limited), established by Dr. Vikram I. Shah in 1994 in Ahmedabad, Gujarat, operates a chain of multispecialty hospitals across India, holding an aggregate bed capacity of over 2000 hospital beds.
• Shalby’s recognition as a multispecialty tertiary hospital chain in the Indian healthcare industry was envisioned by its founder Dr. Vikram Shah – CMD, who has been felicitated by Ethicon India for the development of the ‘OS Needle’.

Working Area

• Shalby Hospital provides inpatient and outpatient healthcare services through 8 fully operational hospitals with an aggregate operational bed count of 781.
• The Hospital also provides outpatient consultative healthcare services through 3 hospitals and 68 Outpatient Clinics.
• The Hospital has 8 shared surgery centers within 3rd party hospitals.
• Shalby Hospitals is a world renowned Joint Replacement Centre today establishing many records. Since 2007, the hospital has successfully performed thousands of joint replacement surgeries. In fact, the Shalby Hospital had a 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India in 2016.
• Apart from a focus on orthopaedics, Shalby hospitals provide advanced levels of care across various specialties such as neurology, cardiac care, critical care, oncology, and nephrology.

How Shably Operates

• Shalby hospitals operate across 5 states and Outpatient Clinics operate across 53 cities in 16 states in India.
• The hospital also has 6 Outpatient Clinics and 1 Shalby Arthroplasty Centre of Excellence (SACE) in Africa, and 2 SACE in the UAE.
• The company is expanding footprint in western and central India with hospitals being set up in Nashik and Vadodara.

Awards

Shalby receives Healthcare Service Provider Company of the Year – 2013

Shalby Hospitals has been bestowed upon with another award at 5th Annual India Healthcare Excellence Awards 2013 by Frost & Sullivan held at The Lalit, Mumbai on 27th September 2013. Shalby is recognized “Healthcare Service Provider Company of the year (Revenue less than Rs 500 Crore)” by Frost & Sullivan during the award night held with grand celebrations.

FICCI Healthcare Excellence Award – 2011

Shalby has received FICCI Operational Excellence Award, 2011.

Rajiv Gandhi National Quality Award – 2010

Shalby Hospitals, has added another feather in its cap by winning the prestigious Rajiv Gandhi National Quality Award 2010, instituted by the Union Ministry of Consumer Affairs, Food and Public Distribution.

Patient Served

Since March 2007, Shalby has conducted an aggregate of 92,100 surgeries, and provided healthcare services to an aggregate of 1,025,533 patients, consisting 133,652 inpatients and 891,881 outpatients.

Company Promoters

• Dr Vikram Shah
• Dr Darshini Shah
• Shanay Shah
• Zodiac Mediquip Limited and
• Shah Family Trust

IPO Opening / Closing Dates & Listing

IPO Details – Price, Minimum Bid and Other

Financial Performance

Revenues

The Company shows steady revenue growth in recent years. Top-line has been increasing regularly for the last 5 years and jumped from INR 168.48 crore in FY 2012 to INR 244.08 crore for the period ended 31 DEC 2016.

Profits

Though the company has shown steady growth in revenue, the company has also registered consistent growth in profits in these 5 years. Starting from INR 25.806 crore of profits in FY 2012, the company’s earnings improved to INR 47.511 crore for the period ended 31 DEC 2016.

CONCLUSION –

Considering company’s valuation and financial parameters, FinBlab recommends NEUTRAL ratings on Shalby Hospital IPO

Previous Article – TYRE SECTOR: Q2 RESULTS AND ANALYSIS

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I ( Vishal Dalwadi ) or “Fin Blab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

The post Shalby Hospital IPO – COMPANY PROFILE, IPO DATE, PRICE BAND, ANALYSIS appeared first on Upcoming ipos: Latest news on stocks, economy & finance.